Pharmacy and Pharmacology Communications

Synthesis and Biological Activity of New Melatonin Receptor Ligands
pp. 49-60(12)
Authors: Charton I.; Mamai A.; Bennejean C.; Renard P.; Delagrange P.; Morgan P.J.; Howell H.E.; Gourdel-Martin M.E.; Viaud M.C.; Guillaumet G.

5-Halobenzothiophene Analogues of Melatonin: Synthesis and Affinity for mt₁ and MT₂ Receptors in Man
pp. 61-65(5)
Authors: Leclerc V.; Beaurain N.; Depreux P.; Bennejean C.; Delagrange P.; Boutin J.; Lesieur D.

1,2,3,4,5,6-Hexahydrobenzo[h][1,6]naphthyridin-5-ones: 5-HT₇ Receptor Affinity
pp. 67-71(5)
Authors: Hinschberger A.; Gillard A.C.; Dauphin F.; Rault S.

Relationship Between the 5-HT₃ Receptor Pharmacophore and the Conformations of 5-Hydroxytryptamine
pp. 73-76(4)
Authors: Daveu C.; Bureau R.; Rault S.

Pharmacomodulation Studies of Torasemide Leading to Original Non-carboxylic Thromboxane A₂ Receptor Antagonists
pp. 77-82(6)
Authors: Dogné J.M.; De Leval X.; Neven P.; Rolin S.; Wouters J.; Delarge J.; Masereel B.

Comparison of the Effects of Nimesulide and Nimesulide-L-lysine on PGE₂ Production by COX-1 and COX-2 and on Chondrocyte Metabolism In-vitro
pp. 83-87(5)
Authors: de Leval X.; Henrotin Y.; Labasse A.; Reginster J.-Y.; Neven P.; Delarge J.; Somers F.; Masereel B.; Pirotte B.; Dogné J.-M.

Synthesis and Biological Effects of New 3-Alkylamino-4H- 1,2,4-Benzothiadiazine 1,1-Dioxides on Insulin-secreting Cells
pp. 89-95(7)
Authors: Somers F.; de Tullio P.; Boverie S.; Dogné J.M.; de Leval X.; Antoine M.-H.; Lebrun P.; Pirotte B.

Effects of 3-Alkylamino-7-chloro-4H-pyrido[2,3-e]-1,2,4-thiadiazine 1,1-Dioxides on Smooth Muscle Contraction
pp. 97-100(4)
Authors: Ouedraogo R.; Fontaine J.; Antoine M.-H.; Pirotte B.; Lebrun P.

Synthesis and Preliminary Pharmacological Evaluation of New 6-cyano-2,3-dihydro-5H-oxazolo[3,2-a]pyrimidin-5-ones and 2-ethyl(methylenecyanoacetate)-2-iminooxazolidines
pp. 101-105(5)
Authors: Chaimbault C.; Bosc J.J.; Jarry C.; Daulouede S.; Vincendeau P.